Follow
Precision oncology biomarkers testing
Biomarker testing for oncology aims to identify genes, proteins, or tumor markers that are specific to the cancer. Understanding the biomarkers present in a certain cancer helps optimize therapeutic regimens and inform personalized medicine strategies.
What's Popular in Precision oncology biomarkers testing
-
APR 27, 2023Clinical & Molecular DX
Prostate cancer impacts men from all ethnic and racial groups, and has particularly high mortality rates compared to oth ...Written By: Carmen LeitchAUG 08, 2022Immunology
One of the primary objectives for the application of flow cytometry in any testing environment should be measurement ass ...Sponsored By: Slingshot Biosciences, Inc.MAR 04, 2021Clinical & Molecular DX
A newly-developed tool could help physicians monitor the performance of colorectal cancer therapies simply by examining ...Written By: Tara FernandesNOV 09, 2020Genetics & Genomics
Liquid biopsies are tests that look for biomarkers in the blood, which can help inform the treatment of cancer. The tool ...Written By: Carmen LeitchNOV 03, 2020Genetics & Genomics
Genetic sequencing technologies have rapidly advanced, reducing the time required to sequence the entire human genome fr ...Written By: Carmen Leitch
APR 27, 2023
Clinical & Molecular DX
Prostate cancer impacts men from all ethnic and racial groups, and has particularly high mortality rates compared to oth
...
Written By:
Carmen Leitch
AUG 08, 2022
Immunology
One of the primary objectives for the application of flow cytometry in any testing environment should be measurement ass
...
Sponsored By:
Slingshot Biosciences, Inc.
MAR 04, 2021
Clinical & Molecular DX
A newly-developed tool could help physicians monitor the performance of colorectal cancer therapies simply by examining
...
Written By:
Tara Fernandes
NOV 09, 2020
Genetics & Genomics
Liquid biopsies are tests that look for biomarkers in the blood, which can help inform the treatment of cancer. The tool
...
Written By:
Carmen Leitch
NOV 03, 2020
Genetics & Genomics
Genetic sequencing technologies have rapidly advanced, reducing the time required to sequence the entire human genome fr
...
Written By:
Carmen Leitch
JAN 30, 2019
Cancer
Doctors from the Memorial Sloan Kettering Cancer Center in New York recently published a paper in Nature detai
...
Written By:
Amy Loriaux
AUG 16, 2018
Clinical & Molecular DX
Researchers have developed a proof-of-concept technique that allows them to detect brain tumor biomarkers with a simple
...
Written By:
Futurity (futurity.org)
AUG 10, 2018
Immunology
Cancer cells release PD-L1 containing exosomes that circulate in the blood and stop T cells before they can reach tumors
...
Written By:
Caitlin Williams
JUN 05, 2018
Cancer
Phase III clinical trial research shows evidence that early breast cancer patients with common breast cancer type do not
...
Written By:
Mauri Brueggeman
-
NOV 16, 2023 | 8:00 AM
To bring your cutting-edge cell and gene therapies to the patients that need them as quickly as possible, you need access to the most knowledgeable scientists, innovative technologies, metho...NOV 01, 2023 | 8:00 AM
To bring your cutting-edge cell and gene therapies to the patients that need them as quickly as possible, you need access to the most knowledgeable scientists, innovative technologies, metho...OCT 10, 2023 | 10:00 AMC.E. CREDITS
For patients with advanced non-small cell lung cancer (NSCLC), tissue samples are typically small biopsies. These samples undergo standard of care evaluation for >10 biomarkers to identif...MAR 30, 2023 | 12:05 PM
In this study, we evaluated the concordance of targeted sequencing results between paired ctDNA and tumor samples from early breast cancers scheduled for curative surgery with or without adj...Speaker: Dr. Chi-Cheng Huang, PhDPresented at: OncomineWorld 2023: A Virtual NGS Education Meeting
MAR 30, 2023 | 12:05 PM
In this study, we evaluated the concordance of targeted sequencing results between paired ctDNA and tumor samples from early breast cancers scheduled for curative surgery with or without adj...
Speaker:
Dr. Chi-Cheng Huang, PhD
Presented at: OncomineWorld 2024: A Virtual NGS Education Meeting
NOV 16, 2023 | 8:00 AM
To bring your cutting-edge cell and gene therapies to the patients that need them as quickly as possible, you need access to the most knowledgeable scientists, innovative technologies, metho...
NOV 01, 2023 | 8:00 AM
To bring your cutting-edge cell and gene therapies to the patients that need them as quickly as possible, you need access to the most knowledgeable scientists, innovative technologies, metho...
OCT 10, 2023 | 10:00 AM
C.E. CREDITS
For patients with advanced non-small cell lung cancer (NSCLC), tissue samples are typically small biopsies. These samples undergo standard of care evaluation for >10 biomarkers to identif...
MAR 30, 2023 | 12:05 PM
In this study, we evaluated the concordance of targeted sequencing results between paired ctDNA and tumor samples from early breast cancers scheduled for curative surgery with or without adj...
Speaker:
Dr. Chi-Cheng Huang, PhD
Presented at: OncomineWorld 2023: A Virtual NGS Education Meeting
MAR 30, 2023 | 12:05 PM
In this study, we evaluated the concordance of targeted sequencing results between paired ctDNA and tumor samples from early breast cancers scheduled for curative surgery with or without adj...
Speaker:
Dr. Chi-Cheng Huang, PhD
Presented at: OncomineWorld 2024: A Virtual NGS Education Meeting
AUG 24, 2022 | 8:00 AM
Date: August 24, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Next Generation Sequencing (NGS) has evolved rapidly since the first sequencing platforms were commercially released ne...
OCT 07, 2021 | 12:00 PM
Across oncology applications, from research to molecular testing and pharmaceutical development, the ability to identify potentially actionable genetic alterations and exploit the molecular...
Speaker:
Beate Litzenburger, Ph.D.
, Sheryl Elkin, PhD
JUN 10, 2021 | 9:05 AM
High volume clinical MS proteomic evaluation of plasma samples enriched for exosomes offering a real-time and non-invasive perspective of changing maternal and fetal tissues....
Speaker:
Kevin Rosenblatt, MD, PhD
Presented at: Shaping the Future of LC-MS in Life Science Together
APR 29, 2021 | 1:35 PM
In examining the potential adoption of the Oncomine Precision Assay, University of Texas Health had several criteria to consider, including the need for highly accurate detection of small sa...
Speaker:
Leomar Ballester, MD, PhD
Presented at: OncomineWorld 2022: A Virtual NGS Education Meeting
